| Dr Kate Elizabeth Mccarn, MD | |
|
501 Se 172nd Ave, Vancouver, WA 98684-9542 | |
| (360) 882-2778 | |
| (360) 604-1784 |
| Full Name | Dr Kate Elizabeth Mccarn |
|---|---|
| Gender | Female |
| Speciality | Plastic And Reconstructive Surgery |
| Experience | 19 Years |
| Location | 501 Se 172nd Ave, Vancouver, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982857298 | NPI | - | NPPES |
| 2043466 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | MD60533284 (Washington) | Secondary |
| 207YX0007X | Otolaryngology - Plastic Surgery Within The Head & Neck | MD60533284 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Legacy Salmon Creek Medical Center | Vancouver, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Vancouver Clinic Inc Ps | 3173436490 | 471 |
News Archive
One promising new strategy to treat diabetes is to give patients insulin that circulates in their bloodstream, staying dormant until activated by rising blood sugar levels.
Safe Kids Pennsylvania today announced that they will exhibit at the 2012 Pennsylvania Farm Show to reach thousands of parents and caregivers with information about preventing childhood injuries.
Arno Therapeutics, Inc. announced today that its investigational compound known as AR-42 has been granted orphan-drug designation by the European Medicines Agency's (EMA) Committee for Orphan Medicinal Products for the treatment of neurofibromatosis type 2 (NF2).
A better approach to advanced illness, including fewer hospitalizations, could improve quality of life and satisfaction for the sickest patients -; and save $25 billion in annual health-care costs, according to Gundersen Health System.
Obese women may be putting themselves at greater risk of breast cancer by not undergoing regular screening.
› Verified 6 days ago
| Entity Name | The Vancouver Clinic Inc Ps |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992759427 PECOS PAC ID: 3173436490 Enrollment ID: O20031111000793 |
News Archive
One promising new strategy to treat diabetes is to give patients insulin that circulates in their bloodstream, staying dormant until activated by rising blood sugar levels.
Safe Kids Pennsylvania today announced that they will exhibit at the 2012 Pennsylvania Farm Show to reach thousands of parents and caregivers with information about preventing childhood injuries.
Arno Therapeutics, Inc. announced today that its investigational compound known as AR-42 has been granted orphan-drug designation by the European Medicines Agency's (EMA) Committee for Orphan Medicinal Products for the treatment of neurofibromatosis type 2 (NF2).
A better approach to advanced illness, including fewer hospitalizations, could improve quality of life and satisfaction for the sickest patients -; and save $25 billion in annual health-care costs, according to Gundersen Health System.
Obese women may be putting themselves at greater risk of breast cancer by not undergoing regular screening.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kate Elizabeth Mccarn, MD Po Box 873010, Vancouver, WA 98687-3010 Ph: (360) 882-2778 | Dr Kate Elizabeth Mccarn, MD 501 Se 172nd Ave, Vancouver, WA 98684-9542 Ph: (360) 882-2778 |
News Archive
One promising new strategy to treat diabetes is to give patients insulin that circulates in their bloodstream, staying dormant until activated by rising blood sugar levels.
Safe Kids Pennsylvania today announced that they will exhibit at the 2012 Pennsylvania Farm Show to reach thousands of parents and caregivers with information about preventing childhood injuries.
Arno Therapeutics, Inc. announced today that its investigational compound known as AR-42 has been granted orphan-drug designation by the European Medicines Agency's (EMA) Committee for Orphan Medicinal Products for the treatment of neurofibromatosis type 2 (NF2).
A better approach to advanced illness, including fewer hospitalizations, could improve quality of life and satisfaction for the sickest patients -; and save $25 billion in annual health-care costs, according to Gundersen Health System.
Obese women may be putting themselves at greater risk of breast cancer by not undergoing regular screening.
› Verified 6 days ago
Mr. David Charles Bloom, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2621 Ne 134th St Ste 300, Vancouver, WA 98686 Phone: 360-882-2778 | |
Dr. Douglas R Myers, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 8614 E Mill Plain Blvd, Ste #100, Vancouver, WA 98664 Phone: 360-254-7725 Fax: 360-254-7727 | |
Sande Bartels Irwin, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 203 Se Park Plaza Dr, Suite 140, Vancouver, WA 98684 Phone: 360-449-7032 Fax: 360-449-7040 | |
Dr. Todd Harry Berinstein, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2121 Ne 139th St #245, Vancouver, WA 98686 Phone: 360-326-3966 Fax: 360-859-3807 | |
Andrew Sheppert, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 700 Ne 87th Ave, Vancouver, WA 98664 Phone: 360-397-1500 Fax: 360-397-3128 | |
Dr. Philemon Lynn Anderson, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 718 Ne 87th Ave Ste 100, Vancouver, WA 98664 Phone: 360-828-1346 Fax: 360-828-7627 | |
Dr. Adam Spach Wilson, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1405 Se 164th Ave Ste 102, Vancouver, WA 98683 Phone: 360-256-4425 Fax: 360-254-1844 |